Ali Samiian

Ali Samiian is the Founder and Principal of Poplar Access Advisors, a fractional market access and reimbursement firm serving medtech and biotech companies across the U.S. and international markets. With over 20 years of experience in the pharmaceutical and medical device sectors, Ali has led market access, sales, and strategic planning initiatives across the U.S., Europe, Canada, and Asia Pacific.

Work Background

• Global Head of Market Access and Reimbursement Services, Saluda Medical
  Led global market access function for closed loop spinal cord stimulation.
• VP of Regulatory Affairs and Reimbursement, StoParkinson Healthcare Systems
  Directed reimbursement strategy for a clinical-stage, non-invasive wearable device for Parkinson’s Disease.
• Sr. Director of Reimbursement, Cala Health
  Secured new HCPCS codes and achieved the highest payment amount for a non-invasive neuromodulation device.
• Global Head of Market Access, Health Economics & Pricing, Abbott Diabetes Care.
  Built and led a global team to secure reimbursement for a first-in-class continuous glucose sensing technology, contributing to sales exceeding $5B.
• Various roles of increasing responsibility, Novartis Pharmaceuticals
  Launching several first-in-class products in Neurology and Eye Care.
• Sr Policy Advisor to the minister of Health, Government of Ontario
  Led reimbursement and funding policy, shaping coverage frameworks for drugs, diagnostics, and health services.

Education

• JD, Osgoode Hall Law School, Canada
• MBA, Schulich School of Business, Canada
• MSc in Health Economics, Policy and Management, London School of Economics